title: The effect of N-stearoylethanolamine on cholesterol content, fatty acid composition and protein carbonylation level in rats with alimentary obesity-induced insulin resistance.
abstract: The effect of N-stearoylethanolamine (NSE) on liver free fatty acid composition, cholesterol content and carbonylated protein level in rats with obesity-induced insulin resistance (IR) was studied in the work. The experimental insulin resistance was induced by prolonged high fat diet (58% of energy derived from fat) for 6 months combined with one injection of low-dose (15 mg/kg) of streptozotocin. The lipid assay showed a rise in liver free cholesterol content anda significant reduction in cholesterol esters level. Analyzing liver fatty acid composition, a decrease in polyunsaturated of fatty acid (PUFA) level and an increase in monounsaturated fatty acid (MUFA) content was found. Fatty acid imbalance with high content of MUFA was associated with elevated level ofprotein carbonylation. The NSE administration (50 mg/kg of body weight) for 2 weeks decreased free cholesterol content, increased cholesterol esters level and reduced free oleic fatty acid content in the liver of rats with IR. The effect of NSE on lipid imbalance led to a decrease in protein carbonylation level that may result in improvement of transmembrane protein function under obesity-induced insulin resistance state.
authors: O V
authors: OV
authors: Onopchenko
authors: G V
authors: GV
authors: Kosiakova
authors: E F
authors: EF
authors: Meged
authors: V M
authors: VM
authors: Klimashevsky
authors: N M
authors: NM
authors: Hula
mesh_terms: D000818:Animals; D002784:Cholesterol / Q000378:metabolism*; D059305:Diet, High-Fat; D004041:Dietary Fats / Q000009:adverse effects; D004983:Ethanolamines / Q000494:pharmacology*; D005229:Fatty Acids, Monounsaturated / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007333:Insulin Resistance; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009765:Obesity / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D050050:Protein Carbonylation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013229:Stearic Acids / Q000494:pharmacology*; D013311:Streptozocin / Q000008:administration & dosage
chemical_list: D004041:Dietary Fats; D004983:Ethanolamines; D005229:Fatty Acids, Monounsaturated; D005230:Fatty Acids, Nonesterified; D005231:Fatty Acids, Unsaturated; D000960:Hypolipidemic Agents; C408368:N-stearoylethanolamine; D013229:Stearic Acids; D013311:Streptozocin; D002784:Cholesterol